This city in eastern Cuba is preparing today for the third phase of clinical trials of the Abdala Covid-19 vaccine candidate, which it will share with Guantanamo, after conducting two previous ones with good results.
HeberFERON, a drug developed by the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym) for the treatment of skin cancer, could become another therapeutic alternative for diseases such as brain tumors and renal carcinomas.
Read more Cuban experts test HeberFERON in treatment of brain tumors and kidney cancerPage 365 of 467